Vincenza Cifarelli | lipid | Best Researcher Award

Dr. Vincenza Cifarelli | lipid | Best Researcher Awardย 

Dr. Vincenza Cifarelli, Saint Louis University School of Medicine, United States.

๐Ÿ“ Vincenza Cifarelli, PhD is an Assistant Professor (Tenure Track) at Saint Louis University School of Medicine. Her research focuses on vascular and lymphatic endothelium in metabolic health, tissue remodeling, and inflammation. She has received prestigious grants, including NIH and NSF funding, and has authored high-impact publications in Nature Communications, JCI, and Gastroenterology. Her groundbreaking studies on lipid metabolism, obesity, and lymphatic function have earned her multiple awards, including the Altschul Lectureship Award and President Research Fund. ๐ŸŽ“๐Ÿ”ฌ

Professional Profile

๐ŸŽ“ Early Academic Pursuits

Dr. Vincenza Cifarelli embarked on her academic journey at Universitร  degli Studi di Modena e Reggio Emilia, where she earned an MS in Bioscience and Biotechnology (2005). She further pursued a Ph.D. in Diabetes at the University of Pittsburgh (2011), focusing on endothelial dysfunction and monocyte activation in children with Type 1 Diabetes. Following her doctoral studies, she undertook postdoctoral research at The University of Texas, Austin (2012), and NIH-funded training at Washington University, St. Louis (2014), where she deepened her expertise in obesity and lipid metabolism.

๐Ÿ’ผ Professional Endeavors

Dr. Cifarelli embarked on a postdoctoral journey at The University of Texas, Austin, focusing on diabetes and cancer in 2012. She further honed her expertise in metabolism at Washington University, St. Louis, Missouri, under an NIH T32 training grant, exploring obesity-related mechanisms until 2014. Her career trajectory led her to Washington Universityโ€™s School of Medicine, where she progressed from Instructor (2015-2018) to Research Assistant Professor of Medicine (2018-2021) at the Center for Human Nutrition. In 2022, she joined Saint Louis University School of Medicine as a Tenure-Track Assistant Professor in the Department of Pharmacology and Physiology.

๐Ÿ”ฌ Contributions and Research Focus On lipidย 

Dr. Cifarelliโ€™s research program is centered on the intricate relationship between vascular and lymphatic endothelium, lipid metabolism, and inflammation in metabolic disorders. Her significant contributions include identifying bi-directional regulation between lipid metabolism and lymphatics using innovative preclinical models. She has led pioneering studies on adipose tissue oxygenation, inflammation, and obesity pathophysiology. Through cutting-edge techniques such as single-cell RNA sequencing, proteomics, and confocal imaging, her laboratory continues to unravel mechanisms linking lymphatic dysfunction and adipose tissue remodeling.

๐ŸŒ Impact and Influence

Dr. Cifarelliโ€™s work has made a profound impact on the fields of metabolic disease and endothelial biology. Her research has expanded the understanding of lipid metabolismโ€™s role in lymphatic function, influencing both basic science and translational medicine. As a faculty member, she actively contributes to academic committees, serving as a member of the Admission Committee for the MD/PhD program and the PhD Core Program in Biomedical Sciences at SLU-SOM. Her work continues to inform therapeutic strategies for obesity, diabetes, and cardiovascular diseases.

๐Ÿ“š Academic Citations

Dr. Cifarelli has published extensively in high-impact journals, with key contributions in Nature Communications, Journal of Clinical Investigation, Gastroenterology, and Journal of Lipid Research. Her studies on lymphatic endothelial function, insulin signaling, and lipid metabolism have received wide recognition and citations, positioning her as a leading expert in her domain.

๐Ÿ… Awards and Honorsย 

Dr. Cifarelli has been recognized with numerous prestigious awards, including:

  • 2024 President Research Fund, SLU-SOM
  • 2023 Altschul Lectureship Award, University of Saskatchewan, Canada
  • 2023 SLU Institute for Drug and Biotherapeutic Innovation Pilot & Feasibility Award, IDBI
  • 2018-2019 Digestive Disease Research Cores Center (DDRCC) Pilot & Feasibility Award
  • 2015-2017 Nutrition and Obesity Research Core (NORC) Pilot & Feasibility Award
  • 2013-2014 T32 Cardiovascular Training Grant, Washington University
  • 2009-2011 Pre-doctoral Fellowship, Childrenโ€™s Hospital of Pittsburgh
  • 2018 Roger Davis Investigator Award for Transitional Faculty, KERN Conference
  • 2017 & 2015 Lymphatic Education and Research Network Travel Award
    Her accolades reflect her exceptional contributions to metabolic and endothelial research, solidifying her legacy as a leading scientist in the field.

๐Ÿš€ Legacy and Future Contributions

With her ongoing NIH and NSF-funded projects, Dr. Cifarelli is paving the way for groundbreaking discoveries in endothelial and metabolic research. She is at the forefront of developing innovative models to understand lipid-lymphatic interactions, with potential clinical applications in treating metabolic syndromes. Her commitment to mentorship and academic leadership ensures a lasting impact on future generations of researchers.

Publications Top Notes

๐Ÿ“– The intestinal lymphatic system: functions and metabolic implications
โœ๏ธ V Cifarelli, A Eichmann
๐Ÿ“š Cellular and Molecular Gastroenterology and Hepatology 7(3), 503-513
๐Ÿ”ข Citations: 154 ๐Ÿ“† Year: 2019

๐Ÿ“– Associations among adipose tissue immunology, inflammation, exosomes and insulin sensitivity in obesity & NAFLD
โœ๏ธ A Fuchs, D Samovski, GI Smith, V Cifarelli, et al.
๐Ÿ“š Gastroenterology 161(3), 968-981.e12
๐Ÿ”ข Citations: 124 ๐Ÿ“† Year: 2021

๐Ÿ“– Human C-peptide antagonizes high glucose-induced endothelial dysfunction via NF-ฮบB pathway
โœ๏ธ P Luppi, V Cifarelli, et al.
๐Ÿ“š Diabetologia 51, 1534-1543
๐Ÿ”ข Citations: 123 ๐Ÿ“† Year: 2008

๐Ÿ“– Decreased adipose tissue oxygenation associates with insulin resistance in obesity
โœ๏ธ V Cifarelli, SC Beeman, GI Smith, et al.
๐Ÿ“š JCI 130(12), 6688-6699
๐Ÿ”ข Citations: 121 ๐Ÿ“† Year: 2020

๐Ÿ“– Intestinal CD36 & lipid utilization: role in absorption and gut homeostasis
โœ๏ธ V Cifarelli, NA Abumrad
๐Ÿ“š Comprehensive Physiology 8(2), 493
๐Ÿ”ข Citations: 118 ๐Ÿ“† Year: 2018

๐Ÿ“– Metformin & rapamycin reduce pancreatic cancer growth in obese prediabetic mice via microRNA-regulated mechanisms
โœ๏ธ V Cifarelli, LM Lashinger, et al.
๐Ÿ“š Diabetes 64(5), 1632-1642
๐Ÿ”ข Citations: 97 ๐Ÿ“† Year: 2015

๐Ÿ“– Visceral obesity & insulin resistance associate with CD36 deletion in lymphatic endothelial cells
โœ๏ธ V Cifarelli, S Appak-Baskoy, et al.
๐Ÿ“š Nature Communications 12(1), 3350
๐Ÿ”ข Citations: 93 ๐Ÿ“† Year: 2021

๐Ÿ“– Human proinsulin C-peptide reduces high glucose-induced proliferation & NF-ฮบB activation in vascular smooth muscle cells
โœ๏ธ V Cifarelli, P Luppi, et al.
๐Ÿ“š Atherosclerosis 201(2), 248-257
๐Ÿ”ข Citations: 93 ๐Ÿ“† Year: 2008

๐Ÿ“– C-peptide reduces endothelial cell apoptosis & reactive oxygen species generation in high glucose conditions
โœ๏ธ V Cifarelli, X Geng, et al.
๐Ÿ“š Diabetologia 54, 2702-2712
๐Ÿ”ข Citations: 92 ๐Ÿ“† Year: 2011

๐Ÿ“– CD36 Deficiency impairs small intestinal barrier & induces subclinical inflammation
โœ๏ธ V Cifarelli, S Ivanov, et al.
๐Ÿ“š CMGH 3(1), 82-98
๐Ÿ”ข Citations: 54 ๐Ÿ“† Year: 2017

๐Ÿ“– VEGFR-3 signaling regulates triglyceride retention & absorption in intestine
โœ๏ธ T Shew, NE Wolins, V Cifarelli
๐Ÿ“š Frontiers in Physiology 9, 1783
๐Ÿ”ข Citations: 30 ๐Ÿ“† Year: 2018

๐Ÿ“– Obesity, diabetes & cancer: a mechanistic perspective
โœ๏ธ V Cifarelli, SD Hursting
๐Ÿ“š Int. J. Diabetology & Vascular Disease Research
๐Ÿ”ข Citations: 13 ๐Ÿ“† Year: 2015

๐Ÿ“– The role of the lymphatic system in lipid & energy metabolism, and immune homeostasis during obesity & diabetes
โœ๏ธ V Cifarelli, H Chen, JP Scallani
๐Ÿ“š Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids
๐Ÿ“† Year: 2022